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Increasing Concentrations of 17P-Estradiol Has Differential Effects on Secretion of
Luteinizing Hormone and Follicle-Stimulating Hormone and Amounts of mRNA for
Gonadotropin Subunits during the Follicular Phase of the Bovine Estrous Cycle'
AS. CUPP, F.N. KOJIMA, M.S. ROBERSON,3 T.T. STUMPF, 4 M.W. WOLFE, 5 L.A. WERTH, 6 RJ. KITTOK,
H.E. GROTJAN, and J.E. KINDER 2
Department of Animal Science, University of Nebraska, Lincoln, Nebraska 68583-0908
ABSTRACT
The hypothesis tested was that 17[0-estradiol (E,) would increase amounts of mRNA for oa, LH[, and FSH[ subunits during
the follicular phase of the estrous cycle prior to the preovulatory surge of gonadotropins in cows. On Day 16 (Day 0 = estrus)
of the estrous cycle, all cows were treated with prostaglandin F,. (PGF,2). Cows served as intact controls (CONT, n = 4) were
ovariectomized (OVX, n = 5), or were ovariectomized and administered E, (OVXE, n = 6) in increasing doses starting at the
time of treatment with PGF,. Cows were bled for 6 h before and for 40 h after PGF,, treatment to characterize pulsatile secretion
of LH and FSH. Forty hours after PGF, treatment, pituitaries were collected for evaluation of amounts of mRNA for ca, LH[i, and
FSHI3 subunits. Amplitude of LH pulses was greater (p < 0.05) in cows from the OVXE than from the CONT group. Concentrations of FSH were greater in cows from both the OVXE and OVX (p < 0.01) groups than from the CONT group. Amounts
of mRNA for oa and FSHI3 subunits were greater (p < 0.01) in pituitaries of cows from the OVX than from the CONT or OVXE
groups. Amounts of mRNA for LHP subunit in pituitaries of cows from the OVX group tended to be greater (p < 0.08) than
from the CONT group. Cows in the OVXE group tended (p < 0.08) to have greater amounts of mRNA for FSH[B subunit than
did CONT cows. Amounts of mRNA for a and LHp subunits in cows from the OVXE and CONT groups did not differ (p >
0.10). Pituitary weight and content of LH and FSH were not different (p > 0.10) among cows of the different groups. Ovariectomy
resulted in enhanced secretion of gonadotropins and increased amounts of mRNA for gonadotropin subunits above values detected in CONT cows. Ovariectomized cows administered E2, in follicular-phase patterns had amounts of mRNA for a and LH[
similar to those in CONT cows even though secretion of LH was enhanced in the OVXE group. We reject our hypothesis and
conclude that E, has a divergent role in regulation of gonadotropins. Release of LH is enhanced by E,, but E, reduced mRNA
for gonadotropin subunits (tended to reduce mRNA for FSHPI subunit) in ovariectomized cows to amounts detected in intact
cows during the follicular phase of the bovine estrous cycle.

INTRODUCTION
During the follicular phase of the estrous cycle in cows,
increased 173-estradiol (E2) enhanced secretion of LH [1, 2].
Estradiol modulates LH secretion in the ewe by influencing
secretion of LHRH [3] and up-regulating receptors for LHRH
at the pituitary [4, 5]. Enhanced secretion of LHRH in rodents results in a similar up-regulation of receptors for LHRH
[6, 7], and enhanced secretion of LH is a consequence of
the increased population of receptors for LHRH.
Stimulation of gonadotrophs by LHRH contributes to the
production of mRNA for gonadotropin subunits (ewe [8];
rat [9, 10]). Pulsatile secretion of LHRH is required to maintain greater amounts of mRNA for LH3 (ewe [11]; rat [12])
and FSH3 subunits (ewe [11]). Increases in the pulse freAccepted September 21, 1994.
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'Published as paper No. 10525, Journal Ser. Nebraska Agr. Res. Div., Research
supported by USDA CRGO 88-37240-3966.
2
Correspondence: James E. Kinder, A224J Animal Sciences, University of Nebraska, Lincoln, NE 68583-0908. FAX: (402) 472-6362.
'Current address: Department of Cell Biology and Anatomy, Oregon Health Sciences University, Portland, OR 97201.
'Current address: Department of Animal Science, University of Missouri, Columbia, MO 65211.
5
Current address: Department of Pharmacology, Case Western Reserve University,
Cleveland, OH 44106.
6
Current address: Department of Veterinary and Biomedical Sciences, University
of Nebraska, Lincoln, NE 68583-0905.

quency of LHRH (rat [13]) or continuous infusion of LHRH
(ewe [11]) results in preferential synthesis of ot subunit mRNA.
Therefore, alterations in pattern of LHRH secretion from
the hypothalamus results in changes in amounts of mRNA
for gonadotropin subunits.
Modulation of pulse frequency of LHRH occurs during
different physiological states. Pulse frequency of LHRH is
increased during sexual maturation in rats [14], during the
follicular phase of the menstrual cycle in primates [15-17],
and prior to the preovulatory surge of gonadotropins in
ewes [18, 19]. Administration of progesterone, E2, or both
steroids in combination is hypothesized to regulate the pattern of secretion of LHRH or up-regulate receptors for LHRH
to cause increased production of mRNA for the LH or FSH
subunit [20, 21].
In the ewe, amounts of mRNA for both a and LHP subunits increase around estrus, whereas amounts of mRNA for
FSH3 subunit are minimal [21]. In contrast, in experiments
where E2 was administered chronically to ewes, suppression of mRNA for or, LHP [22], and FSH[ subunits occurred
[23]. Experiments have not been conducted in cows to determine the effect of a physiological increase in E2 during
the follicular phase of the estrous cycle on the amount of
mRNA for gonadotropin subunits. In the present experiment we tested the hypothesis that elevated concentrations
of E2 (similar to follicular phase increases) that result in
288
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increased secretion of LH during the follicular phase of the
bovine estrous cycle prior to the preovulatory surge of gonadotropins would increase amounts of mRNA for oa and
LH3 subunits. In addition, we evaluated the influence of
this change in E2 on the amount of mRNA for FSH{3 subunit.

MATERIALS AND METHODS
Experimental Protocol
All procedures used in this experiment were approved
by the Institutional Animal Care and Use Committee of the
University of Nebraska, Lincoln. Fifteen cows of composite
breeding (1/4 Hereford, 1/4 Angus, 1/4 Red Poll, 1/4 Pinzgauer) were synchronized to a common day of the estrous
cycle with two injections of prostaglandin F2a (PGF2a; Lutalyse® Sterile Solution; The Upjohn Co., Kalamazoo, MI).
On Day 16 (Day 0 = estrus) of the estrous cycle, all cows
were treated with PGF2a. Cows of one group served as controls (CONT, n = 4), and cows in the other two groups
were either ovariectomized (OVX, n = 5) or ovariectomized and administered increasing concentrations of E2
(OVXE, n = 6) via vaginal implants starting at the time of
treatment with PGF2 . Ovariectomies were performed via
high lumbar laparotomy (0 h). After ovariectomy, cows in
the OVXE group received intravaginal implants (polydimethylsiloxane intravaginal implants: 3.35 mm i.d. x 4.65
mm o.d. x 13.5 cm; Dow-Corning, Midland, MI) containing
E2 (Sigma Chemical Co., St. Louis, MO). The number of implants was increased (one per time period) at 0, 10, 15, 20,
and 30 h to mimic the elevation of E2 that occurs during
the follicular phase of the bovine estrous cycle (CONT).
Before PGF2a treatment, indwelling jugular catheters were
inserted, and blood samples were collected at 12-min intervals for 6 h to determine initial concentrations of hormones in circulation. After treatment with PGF2a and initiation of treatments with E2 in cows from the OVX and OVXE
groups, cows were bled every 12-min for four 6-h periods
with 4 hourly samples between each serial blood collection. The last 6-h period of blood collection ended 40 h
after administration of PGF 2a and initiation of treatments
with E2. Blood samples were collected from cows in the
control group after the same protocol of blood collection
as that for ovariectomized cows. These blood samples were
collected to characterize changes in concentration and pulsatile secretion of LH and FSH. Additional blood samples
were collected every 5 h to determine plasma concentrations of E2 and progesterone in circulation.
After the last 6-h period of serial blood collection, pituitaries were collected from all cows within 15 min after
exsanguination. Anterior pituitaries were hemisected, transferred to separate vials, frozen in liquid nitrogen, and stored
at -70°C until amounts of mRNA for a, LH3, and FSH{3
subunits were determined.
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Blood samples for quantification of LH were allowed to
clot at room temperature and were stored at 4°C for 24 h.
Serum was collected after centrifugation at 1520 x g for 15
min and stored at -20°C until assayed for LH. Concentrations of LH in serum samples collected at 12-min intervals
and in pituitary extracts were determined by RIA [24, 25].
Intra- and interassay coefficients of variation for serum LH
assays were 2.5 and 10.5%, respectively. Intra- and interassay coefficients of variation for pituitary extracts were 3.0
and 13.2%, respectively. Sensitivities of the LH assays were
approximately 28 pg/ml in serum and 30 pg/ml in pituitary homogenates.
Concentrations of FSH were analyzed in all serum samples and pituitary extracts by RIA [26, 27]. Intra- and interassay coefficients of variation for FSH assays in serum were
2.1 and 11.2% and in pituitaries were 2.4 and 12.7%, respectively. Sensitivity of the FSH assays were 44 pg/ml in
serum and 74 pg/ml in pituitary homogenates.
Blood samples taken every 5 h were collected in heparinized tubes and centrifuged at 1520 x g for 20 min, and
plasma was stored at -20°C until assayed for progesterone
[28] and E2 [29]. Concentrations of progesterone were determined in a single assay, and the intraassay coefficient of
variation was 5%. Intra- and interassay coefficients of variation for E2 were 2.4 and 17.5%, respectively. Sensitivity of
the progesterone assay was 600 pg/ml, and sensitivities of
the E2 assays were 0.5 pg/ml.
PituitaryExtracts
To determine pituitary content of gonadotropins, hemipituitaries were homogenized in 150 mM NaCl buffered with
50 mM Tris, pH 7.4, containing 0.5% (vol/vol) Triton X-100,
5 mM Na2 EDTA, 1 mM phenylmethylsulphonyl fluoride, 0.5
mg/L leupeptin, and 200 U/ml aprotinin (1.0 ml/100 mg
wet tissue weight) for 30 sec in a polytron homogenizer
(Brinkman Instruments, Westbury, NY). Pituitary extracts were
clarified by centrifugation at 100 000 x g for 1 h, aliquoted
into 0.5-ml portions (equivalent to 50 mg tissue), and stored
at -70°C until assayed for LH [24, 25] and FSH [25, 26]. Pituitary extracts were also used to quantify differences in
isoforms of LH and FSH among treatments; these data are
presented in a companion paper [30].
Northern and Slot Blot Analysis of Total Cellular RNA
(tcRNA)
Frozen hemi-pituitaries were weighed, and tcRNA was
isolated by homogenization in buffer and centrifugation
through a cesium chloride gradient [22]. Precipitates of tcRNA
were maintained under ethanol at -70°C until Northern (a
and LHP subunits) and slot (FSH]3 subunit) blots were prepared and hybridized to appropriate subunit probes. Procedures to determine amounts of mRNA for a and LHO3 subunits in pituitaries of cows using Northern blots were
described previously [29].
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FIG. 1. Mean concentrations (in pg/ml) of E2 in blood samples for each
group collected every 5 h starting with PGF 2, treatment and/or ovariectomy
and ending at pituitary collection. Pooled SEM = 0.50 pg/ml.

FIG. 2. Mean concentrations (in ng/ml) of progesterone in blood samples for each group collected every 5 h starting with PGF2. treatment and/
or OVX and ending at pituitary collection. Pooled SEM = 0.19 ng/ml.

Briefly, Northern blots were prepared by separating 5
kg of tcRNA from individual hemi-pituitaries in 1.5% agarose gels containing formaldehyde, where 18s and 28s bands
were visualized for efficiency of RNA loading per well. Within
each gel, samples of tcRNA from cows in each treatment
group were represented. Total cellular RNA isolated from
cerebellum and steer pituitaries were used as negative and
positive controls, respectively. Size-separated tcRNA was
subsequently transferred to nitrocellulose membranes (Beth
Research Laboratory, Gaithersburg, MD) by capillary action
and baked at 80°C for 2 h. Plasmids containing cDNA fragments encoding bovine a- [31] and LH3 [32] subunits (generously provided by Dr. Richard Maurer) were used to de32
rive riboprobes that were labeled with ao P-CTP (Amersham
Corp., Arlington Heights, IL).
Slot blots to determine amounts of mRNA for FSHP subunit were prepared with 5 kg of tcRNA and diethylpyrocarbonate distilled water to 10 1l total volume. RNA was
denatured by addition of 20 Il 100% formamide, 7 pl 37%
formaldehyde, and 2 1 20-strength saline sodium citrate
(SSC; single-strength SSC is 0.15 M NaCl and 0.015 M sodium citrate), heated to 68°C for 15 min, and then placed
on ice [33]. Before RNA was loaded onto slot blots, wells
were washed twice with 10-strength SSC (250 l/wash for
each well). Two volumes of 20-strength SSC containing bromophenol blue dye were added to RNA samples and applied to nylon filters (Zeta probe, Bio-Rad Labs., Richmond,
CA) in individual wells on slot blots. The nylon filters were
rinsed four times with 10-strength SSC, dried and baked for
30 min at 800C. The cDNA probe for FSH[3 subunit [34] was
32
prepared by random-primer labeling [35] utilizing (( PdCTP, Amersham Corp.). Heterologous oligonucleotide radioactive probes to rat ox-tubulin (NEN DuPont, Boston, MA;

nucleotides +958 to +987 of rat cDNA) were prepared by
3' end labeling (3' end labeling kit, NEN DuPont) with 35S_
dATP (Amersham Corp.) according to manufacturers' instructions.
Total cellular RNA bound to nylon and nitrocellulose filters were hybridized to o and LHP subunits and 0a-tubulin
probes for 46 h at 60°C. All treatments were represented
on one slot blot that was hybridized to FSHi subunit at
9
45°C for 24 h. Specific activity of probes was 1.5-2.0 x 10
dpm/Rpg. The concentration of radioactive probes was approximately 106 total cpm/ml hybridization buffer (5 ml/
blot). After hybridization, filters were washed at room temperature (3 washes; 20 min/wash) in double-strength SSC,
0.1% SDS and then in 0.2-strength SSC, 0.1% SDS at 60°C.
Specific radiolabeled bands from Northern and slot blots
were visualized and quantified by use of an Ambis Radioanalytic Imaging System. Quantification of the radiolabeled
probe hybridizing to mRNA bound to nitrocellulose or nylon was expressed as net counts per minute detected within
the discrete area of the radiolabeled band.
Statistical Analysis
Values for each characteristic of LH and FSH secretion
were analyzed for the five 6-h periods of serial blood collection. Mean concentrations of LH and FSH (ng/ml), frequency of LH and FSH pulses (pulses/6 h), and amplitude
of LH and FSH pulses (ng/ml) were determined through
the use of algorithms (Pulsar Software, Univ. of Illinois, Urbana, IL, modified for the IBM-PC by J.R. Gitzen and V.D.
Ramirez., Univ. of Illinois, Urbana, IL, [G-values for LH were
G1-5.00, G2-2.80, G3-2.30, G4-10.00, G5-10.00; Gvalues for FSH were: G1-3.20, G2-2.80, G3-2.30, G410.00, G5-10.00]).
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TABLE 1. Concentrations of LH prior to and during treatment period.
Mean LH (ng/ml)

LH pulse
amplitude (ng/ml)

LH Pulse
frequency/12 h

Group

Pretreatment

Treatment

Pretreatment

Treatment

Pretreatment

CONT

0.870

1.74c

1.11a

1.65."c

1.75

OVX

0.89 a

'C
2.30 b

OVXE

0.75"

SEM

0.20
P > 0.10

2 .7 0b

0.32
P < 0.05

1.00 a

2.65 b

1.41a

0.47
P > 0.10

a

Treatment
2.74,.C

1.40 a

4.05 b

3 .07 b

1.00a

0.38
P < 0.01

0.54
P > 0.10

3. 62b

0.65
P < 0.05

ab'CAII values with different superscripts within columns are different at P-values listed and within rows at p < 0.05.

Data regarding the effect of treatment on characteristics
of pulsatile secretion of LH and FSH and plasma samples
of E2 and progesterone were fitted to a linear model containing the fixed effect of blood collection period and the
random effect of cow. Variance components were estimated by means of Restricted Maximum Likelihood algorithms of PROC MIXED in SAS [36, 37]. Repeated measures
were accounted for by assuming an autocorrelation error
structure for residual error that estimates the correlation
among repeated measurements on an individual cow.
Therefore, all parameters for LH and FSH were calculated
over time (four 6-h blood collection periods after PGF2,,)
during the treatment period to determine differences between treatments. The plasma samples collected for E2 and
progesterone (every 5 h) were also analyzed over time to
determine differences among groups.
The means of the characteristics for LH and FSH secretion from the combined blood collection periods after PGF2a
were compared to the initial blood collection (since this
blood collection occurred before administration of treatments). In addition, comparisons for steroid hormone concentration (E2 and progesterone) were made between the
one sample collected before treatments and all collections
after treatment administration. Amount of mRNA for gonadotropin subunits and o-tubulin were compared according to PROC MIXED procedures with contrast statements to
determine differences among treatments [36, 37].
RESULTS
Stage of Estrous Cycle
There were no differences in characteristics of hormones in serum during the initial blood collection period
prior to administration of PGF2a and/or ovariectomy. No
cows in the CONT group exhibited a surge of LH during
the blood collection periods, and large ovulatory follicles
with no evidence of functional CL were present when ovaries were evaluated after collection of pituitary tissue.
Therefore, we conclude that all CONT cows were in the
follicular phase of the estrous cycle throughout the experimental period.
Concentrationsof Steroid Hormones
Data for mean concentrations of E2 are depicted in Figure 1 for each group during the period of blood collection.

Concentrations of E2 were similar in all cows prior to PGF2a
treatment. Cows in the OVXE group had concentrations of
E2 in circulation similar to those of CONT cows (p > 0.10;
Fig. 1). Cows in both the OVXE and CONT groups had greater
(p > 0.05) concentrations of E2 than did OVX cows. Concentrations of E2 remained low in cows from the OVX group
(less than level of sensitivity of the assay) throughout the
experiment. Mean concentrations of progesterone for each
group are depicted in Figure 2. Concentrations of progesterone were similar in cows of all groups (p > 0.10).
Pattern of LH Secretion
Mean concentrations of LH were greater (p < 0.05) in
cows in the OVXE than in the CONT group when compared
over all blood collection periods after PGF2 . treatment (Table 1). Mean concentrations of LH were similar among cows
in the OVX and CONT groups for each of the four 6-h periods of serial blood collection after PGF2. administration
(p > 0.10). Frequency of LH pulses were greater (p < 0.05)
in cows in the OVX group than in the CONT group during
the combined blood collection -periods after PGF2, treatment (Table 1). Amplitude of LH pulses was greater (p <
0.01) in cows in the OVXE group than in the CONT group
during the blood collection periods after PGF 2, was administered (Table 1). The profiles of pulsatile LH secretion
during each of the five periods of serial blood collection
are depicted for representative cows from each treatment
in Figure 3.
Pattern of FSH Secretion
Mean concentrations of FSH were greater in cows in the
OVX and OVXE (p < 0.01) groups than in the CONT cows
during the blood collections after PGF2a treatment (Table
2). However, FSH remained similar (p > 0.10) in cows in
the OVX and OVXE groups during the same time period
(Table 2). During the 6-h period of blood sampling prior
to pituitary collection, cows in the OVX group had greater
concentrations of FSH in circulation than did the cows of
either the OVXE (p < 0.01) or CONT group (p < 0.001;
OVX = 3.38; OVXE = 2.73; CONT = 1.67 ng/ml). In addition, cows in the OVXE group had greater concentrations
of FSH than did cows in the CONT group (p < 0.001).
The patterns of secretion of FSH in cows from the ovariectomized groups were different from the pattern in the
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CONT group (Fig. 3). During the four blood collection periods after initiation of treatment, cows in the OVX and OVXE
groups had a greater (p < 0.01) amplitude of FSH pulses
than did cows from the CONT group (0.57, 0.58, and 0.05
± 0.14 ng/ml, respectively). Cows in the OVXE group had
a greater frequency of FSH pulses than did cows in either
the CONT or OVX groups (1.40, 0.12, 0.97 ± 0.33 pulses/
6 h, respectively). Only two cows in the CONT group had
pulses of FSH during the four serial blood collections after
initiation of treatment, and in both cows pulses of FSH were
low in amplitude (0.32, 0.43 ng/ml). Only two cows (one
OVX and one OVXE) had pulses of FSH during the serial
blood collection prior to treatment.

t

2

Gonadotropin Content and Relative Amounts of mRNA
in Pituitaries
Hemisected pituitary weights (CONT = 929.0, OVXE =
860.3, OVX = 899.4 + 78.2 mg) and concentrations of LH
(CONT = 3.3, OVXE = 3.2, OVX = 2.7 + 0.4 iLg/mg tissue)
and FSH (CONT = 0.088, OVXE = 0.099, OVX = 0.098
0.009 [Lg/mg of tissue) were not different (p > 0.10) among
cows in the different treatment groups. Concentrations of
tcRNA isolated from pituitaries were not affected by treat1 g tcRNA/mg in piment (p > 0.10) and averaged 5
and A260/
of
A260/A280
tuitary tissue. Absorbance ratios
tissues
from
pituitary
A230 were similar (p > 0.05) among
+
and
2.47
1.62
0.03
cows in different groups and averaged
cow
from
- 0.06, respectively. Total cellular RNA isolated
a,
LHI3,
either
cerebellum did not specifically hybridize to
or FSH3 subunit probes.
Relative amounts of a-tubulin detected in tcRNA were
similar (p > 0.10) among pituitary tissues of cows from all
groups (Fig. 4d), indicating that effects of E2 were specific
in modulating amounts of mRNA for the gonadotropin subunits. If there were nonspecific actions of estradiol in increasing amounts of mRNA in the pituitary, amount of mRNA
for a-tubulin would have been influenced by treatment with
Ez. There were greater amounts of mRNA for ac-tubulin in
cerebellum compared to pituitary tissue (p < 0.05).
Amounts of mRNA for oa subunit were greater in cows
in the OVX than in the CONT group (630 ± 55 and 406 ±
62 counts/5 g tcRNA;p < 0.01; Fig. 4a). Amounts of mRNA
for LHI subunit tended to be greater in pituitaries of cows
in the OVX than in the CONT or OVXE groups (225 + 27
and 150 + 30 or 178 ± 25 counts/5 g tcRNA, respectively;
p < 0.08; Fig. 4b). Cows in the OVXE group had amounts
of mRNA for ot and LH3 subunits similar to amounts in CONT
cows (p > 0.10). Amounts of mRNA for FSH3 subunit were
greater in cows of the OVX than in those of the CONT (p
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2=-I

-6-4-2

. 6
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412283,

2238

6 8 10121416182022242628303234363840
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FIG. 3. Profiles of LH and FSH secretion in representative cows from
each treatment group for each of the five periods of serial blood collection,
which followed the protocol described in Material and Methods. Top) CONT,
middle) OVXE, bottom) OVX.
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TABLE 2. Concentrations of FSH prior to and during treatment period.
FSH pulse
amplitude (ng/ml)

Mean FSH (ng/ml)

FSH pulse
frequency/12 h

Group

Pretreatment

Treatment

Pretreatment

Treatment

Pretreatment

Treatment

CONT

1.75 a
1.908
2.01a
0.22
P > 0.10

1.77 a

0.00a

0.058

2 .7 9b

0.1

0 .56 b

0.00
0.40"
0.16 a
0.54
P > 0.10

0.12'
0.97"*
1 .3 9b
0.33
P < 0.01

OVX

OVXE
SEM

2,5 5b

0.24
P < 0.01

a

0.12 a
0.22
P > 0.10

0. 57 b
0.15
P < 0.01

"bAll values with different superscripts within columns are different at P-values listed and within rows at p < 0.05.
*Tends to be different than CONT; (p < 0.08).

< 0.001) or OVXE (p < 0.01) groups (13043 + 1525 and
2833
1705 or 7079 + 1392 count/5 g tcRNA, respectively, Fig. 4c). Cows in the OVXE group tended (p < 0.08)
to have greater amounts of FSH[ subunit mRNA than did
cows from the CONT group.
DISCUSSION
In the present experiment, ovariectomy and treatment
with E2 resulted in enhanced secretion of LH and FSH. Cows
of the OVX group tended to have enhanced amounts of
mRNA for all gonadotropin subunits (, LH3 and FSHI3)
compared to cows of the CONT group. However, amounts
of mRNA for a and LH3 subunits were similar in cows of
the OVXE and CONT groups. Although E2 enhanced secretion of LH, it did not enhance amounts of mRNA for LH
subunits during the follicular phase of the bovine estrous
cycle as we had hypothesized. Therefore, we reject our hypothesis that increasing concentrations of E2 during the follicular phase of the bovine estrous cycle enhance amounts
of mRNA for the LH subunits coincident with the increase
in secretion of LH that occurs during this part of the estrous
cycle.
Many experiments have been conducted to determine
the effect of E2 on steady-state or relative amounts of mRNA
for gonadotropin subunits, with mixed results. Chronic
administration of E2 reduced amounts of mRNA for gonadotropin subunits in vivo [22, 23,38,39]. During periods of
the estrous cycle when concentrations of E2 are greater in
circulation (such as the follicular phase and around estrus),
amounts of mRNA for a and LHP subunits were increased
whereas mRNA for FSHP subunit was minimal [21].
In the present experiment, when E2 was administered to
ovariectomized cows in a pattern that mimicked that of the
follicular phase of the bovine estrous cycle, amounts of mRNA
for all gonadotropin subunits were suppressed compared
to amounts in ovariectomized cows not treated with E2. This
demonstrates the negative effect of physiological concentrations of E2 on amounts of mRNA for a, LHP3, and FSHIB
subunits. Our results in cattle concur with those from experiments in other species (rat [40]; ewe [22, 41]) where
chronically ovariectomized animals were administered either
a constant high or low dose of E2 for relatively long periods
of time.

Secretion of LH (mean concentration and pulse amplitude of LH) was enhanced in ovariectomized cows treated
with increasing concentrations of E2 compared to CONT
cows. Because the pattern of circulating concentrations of
steroids was similar in cows of the OVXE and CONT groups,
ovarian factors may exist that regulate LH secretion other
than ovarian steroids. Possible ovarian factors that could elicit
this effect are unknown; thus, it would be pure conjecture
to speculate on their identity.
Secretion of FSH differs from that of LH because it is
coordinately regulated by ovarian peptides-inhibin and
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activin-as well as LHRH [42]. In sheep, suppression of secretion of FSH is under control of both E2 and inhibin. In
combination, both of these hormones can function synergistically to suppress FSH secretion in ewes [43, 44]. It has
also been suggested that inhibin and E2 function at different
times during the estrous cycle to regulate secretion of FSH
in ewes [23]. Concentrations of plasma FSH during the follicular phase of the ovine estrous cycle could be regulated
primarily by E2; however, during the 24-h period following
the preovulatory surge of LH, E2 may be relatively unimportant with regard to modulation of FSH secretion [45].
Interestingly, cows in both the OVX and OVXE groups
had profiles of FSH secretion with distinct pulses compared
to cows in the CONT group. This difference in pulsatile
secretion of FSH is probably due to the absence of inhibin
or other factors following ovariectomy. Previous research
from our laboratory [46] has indicated that release of FSH
in intact cows is not pulsatile, but the baseline of FSH secretion may be altered during specific days of the estrous
cycle. According to results from the present experiment, E2
does not affect mean concentration of FSH (because there
was no difference in OVXE and OVX groups); however, it
does affect the pattern of FSH secretion. Pulse frequency of
FSH was enhanced by E2 in the absence of other ovarian
factors without increasing mean concentration of FSH. It is
possible that E2 acts at the gonadotroph to regulate release
of FSH as well as LH.
In most animal systems, the amount of mRNA for FSHO
subunit and the secretion of FSH are tightly coupled [47].
Unlike the common ot or LHP subunit mRNA, FSH3 subunit
mRNA is regulated by ovarian factors other than steroids.
Progesterone and E2 decrease steady-state amounts of FSHf
subunit mRNA coordinately with FSH secretion in ovine pituitary cultures [48]. Amounts of FSHj3 subunit mRNA in the
pituitary are suppressed by administration of follicular fluid
or inhibin [47]. Perfusion of pituitaries with inhibin suppresses, while perfusion with activin or LHRH increases, the
amount of mRNA for FSHI3 subunit [49]. It has been postulated that activin and inhibin alter the amount of mRNA
for FSHi subunit by modulating production of mRNA at the
pituitary. In contrast, E2 is hypothesized to elicit actions at
the hypothalamus through altering LHRH secretion, which
causes suppression of mRNA for FSH 3 subunit in ewes [47].
The relationship between the amount of mRNA for FSH{
subunit present in the pituitary to the amount of FSH released from the pituitary of cows has not been evaluated.
In the present experiment, amounts of mRNA for FSHI
subunit were lowest in the CONT group; however, administration of E2 reduced amounts of mRNA in the OVXE group
as well, compared to amounts in the OVX group. These
results are similar to those in rats, where treatment with E2
at the time of ovariectomy reduced mRNA for FSHf subunit
by up to 67% when compared to that of ovariectomized
rats not treated with E2 [50]. Estradiol, therefore, has an important role in modulating amounts of mRNA for FSHI3 sub-

unit, which is independent of other ovarian hormones (such
as inhibin) in the cow. In the present study, E2 had little
effect on mean concentrations of FSH (OVX compared to
OVXE), but it reduced amounts of mRNA for FSH, subunit
independent of other ovarian factors.
The actions of E2 may be elicited post-transcriptionally
instead of through regulation of hypothalamic factors by
altering the half-life of the mRNA for gonadotropin subunits
in the pituitary. Steroid hormones may synergize with ovarian peptide hormones to alter post-transcriptional processing (through stabilization or destabilization). Activin stabilizes mRNA for FSH3 subunit, and inhibin decreases stability
of mRNA for FSHI subunit [48]. Data from the present experiment indicates that E2 can affect amount of mRNA for
all gonadotropin subunits. Whether this is through transcriptional or post-transcriptional processes still remains to
be determined.
Pituitary content of either LH or FSH was not different
in any of the three treatment groups. This was presumably
due to the relatively short duration of treatment (40 h)
compared to that in previous studies. In addition, pituitaries were collected before the preovulatory surge of gonadotropins. Considering both of these factors, secretion of
hormones (LH and FSH) did not deplete the pituitary to
the extent that differences in stores of the gonadotropins
were detected. Collection of pituitaries at earlier time periods (12 or 24 h after PGF2 , treatment) may have resulted
in different amounts of mRNA for gonadotropin subunits
than we observed in the present experiment with pituitary
collection at 40 h after PGF2. treatment. The purpose of
collecting pituitaries at 40 h after PGF2 was to evaluate
amounts of mRNA for gonadotropin subunits at a time when
the pituitary had been exposed to E2 for maximal amounts
of time yet before initiation of the preovulatory surge of
gonadotropins.
We reject our hypothesis because treatment with E2, in
a pattern typical of what occurs during the follicular phase
of the estrous cycle, did not result in enhanced amounts of
mRNA for the gonadotropins. Instead, cows of the OVXE
group had amounts of mRNA for a and LH3 subunits similar to amounts in cows of the CONT group, whereas cows
of the OVX group not treated with E2 had greater amounts
of mRNA for all three subunits than cows of the CONT group.
This occurred at the same time that secretion of LH and
FSH was greater in cows of the OVX and OVXE groups than
in cows of the CONT group. An increased amplitude of LH
pulses released from the pituitary results from treating cows
with E2. This results in greater concentrations of LH in circulation. The amount of mRNA for LH subunits is decreased
as a result of treatment of cows with E2. Estradiol, therefore,
enhances LH release but suppresses amount of mRNA for
LH synthesis in cows. Therefore, during the follicular phase
of the bovine estrous cycle when secretion of LH is enhanced, there is not a corresponding increase in amount
of mRNA for the gonadotropin subunits in cows.

ESTRADIOL REDUCES GONADOTROPIN SUBUNIT mRNAS
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